| 产品编号 | bs-103699P |
| 英文名称 | Recombinant Human TOP2A Protein, N-His |
| 中文名称 | |
| 别 名 | DNA topoisomerase II; alpha isozyme; TOP2A; DNA topoisomerase 2-alpha; TOP2 |
| 克 隆 号 | |
| 理论分子量 | 47.88 kDa |
| 性 状 | Lyophilized |
| 纯 度 | >90% as determined by SDS-PAGE. |
| 缓 冲 液 | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 保存条件 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. [provided by RefSeq, Jul 2010] SWISS: P11388 Gene ID: 7153 拓扑异构酶II是一种能催化DNA 拓扑异构体相互变换，调节DNA三维结构的核酶。与染色质或染色体的组装与分组装、基因组复制、DNA重组、基因转录及DNA损伤后修复等有密切的关系。许多人的恶性肿瘤都有拓扑异构酶II的过表达，因此，拓扑异构酶II是许多化疗药的靶标。大部分以拓扑异构酶II为重要靶标抗肿瘤的化疗药物是通过稳定的DNA与拓扑异构酶II的复合物激发凋亡的。 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
